logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Molecular Exploitation Of Apoptosis Pathways In Prostate Cancer 1st Edition Natasha Kyprianou

  • SKU: BELL-5243422
Molecular Exploitation Of Apoptosis Pathways In Prostate Cancer 1st Edition Natasha Kyprianou
$ 31.00 $ 45.00 (-31%)

0.0

0 reviews

Molecular Exploitation Of Apoptosis Pathways In Prostate Cancer 1st Edition Natasha Kyprianou instant download after payment.

Publisher: Imperial College Press
File Extension: PDF
File size: 2.54 MB
Pages: 232
Author: Natasha Kyprianou
ISBN: 9781848164499, 1848164491
Language: English
Year: 2012
Edition: 1

Product desciption

Molecular Exploitation Of Apoptosis Pathways In Prostate Cancer 1st Edition Natasha Kyprianou by Natasha Kyprianou 9781848164499, 1848164491 instant download after payment.

This book focuses on the functional significance of targeting apoptosis for the treatment of prostate cancer. New concepts on the challenges relating to the development of resistance by androgen-independent tumors are introduced, in terms of the contribution of anoikis and cross-talk of androgens with key growth factor signaling pathways. This volume also provides insightful discussion on the exploitation of the apoptotic and angiogenic synergism towards complete eradication of prostate tumors. Last but not least, it includes reflections on the drug development challenge based on the analysis of data from existing clinical trials.

Related Products